Abstract
The utilization of calcium alginate beads as core carriers for delayed dissolution followed by burst release as a potential method of intestinal site specific drug delivery was investigated. 5-Aminosalicylic acid was spray-coated on dried calcium alginate beads and then coated with different percentages of enteric coating polymer and/or sustained-release polymer. Beads coated with more than 6% (w/w) methacrylic copolymer plastisized with dibutyl sebacate and triethyl citrate resisted release in 2-hr acid fluid challenge and allowed immediate dissolution upon transfer to simulated intestinal fluid. With 6% (w/w) methacrylic copolymer on top of 4% (w/w) ethylcellulose polymer, the major portion of drug did not release in 2 hr of acid treatment or the next 3 hr of simulated intestinal fluid treatment. This dosage form provides the possibility to deliver drug to the lower intestinal tract with minimal early release, followed by sustained release in the colon.
Similar content being viewed by others
REFERENCES
A. K. A. Khan, J. Piris, and S. C. Truelove. An experiment to determine the active therapeutic moiety of sulphasalazine. Lancet 2:892–895 (1977).
M. Campieri, G. A. Lanfranchi, G. Bazzocchi, C. Brignola, F. Sarti, G. Franzin, A. Battocchia, G. Labo, and P. R. D. Monte. Treatment of ulcerative colitis with high-dose 5-aminosalicylic acid enemas. Lancet 2:270–271 (1981).
L. R. Sutherland, F. Martin, S. Greer, M. Robinson, N. Greenberger, F. Saibil, T. Martin, J. Sparr, E. Prokipchuk, and L. Borgen. 5-Aminosalicylic acid enema in the treatment of distal ulcerative colitis, proctosigmoiditis, and proctitis. Gastroenterology 92:1894–1898 (1987).
J. Guarino, M. Chatzinoff, T. Berk, and L. S. Friedman. 5-Aminosalicylic acid enemas in refractory distal ulcerative colitis: Long-term results. Am. J. Gastroenterol. 82:732–737 (1987).
L. C. Karp and S. R. Targan. New enema treatments for inflammatory bowel disease. Digest. Dis. Sci. 33:85s–87s (1988).
M. A. Peppercon. Sulfasalazine and related new drugs. J. Clin. Pharmacol. 27:260–265 (1987).
J. G. Hardy, C. G. Wilson, and E. Wood. Drug delivery to the proximal colon. J. Pharm. Pharmacol. 37:874–877 (1985).
M. J. Dew, P. J. Hughes, M. G. Lee, B. K. Evans, and J. Rhodes. An oral preparation to release drugs in the human colon. Br. J. Clin. Pharmacol. 14:405–408 (1982).
S. N. Rasmussen, S. Bondesen, E. F. Hvidberg, S. H. Hansen, V. Binder, S. Halskov, and H. Flachs. 5-Aminosalicylic acid in a slow-release preparation: Bioavailability, plasma level, and excretion in humans. Gastroenterology 83:1062–1070 (1982).
G. Jarnerot. Newer 5-aminosalicylic acid based drugs in chronic inflammatory bowel disease. Drugs 37:73–86 (1989).
G. K. McEvoy (ed.). AHFS Drug Information, American Society of Hospital Pharmacists, Bethesda, MD, 1990, pp. 1674–1675.
P. N. Shaw, L. Aarons, and J. B. Houston. HPLC analysis of sulfasalazine and its metabolites. J. Pharm. Pharmacol. 32:67p (1980).
G. Bahadir and G. S. U. Munchen. Safe formulations of agrochemicals. Chemosphere 16:615–621 (1987).
W. J. Connick, Jr., J. M. Bradow, W. Wells, K. K. Steward, and T. K. Van. Preparation and evaluation of controlled release formulations of 2,6-dichlorobenzonitrile. J. Agr. Food Chem. 32:1199–1205 (1984).
F. Lim and A. M. Sun. Microencapsulated islets as bioartificial endocrine pancreas. Science 210:908–910 (1980).
P. Sheurich, H. Schnabl, U. Zimmermann, and J. Klein. Immobilization and mechanical support of individual protoplasts. Biochim. Biophys. Acta 598:645–651 (1980).
A. Khosla, L. C. Hardy, and J. W. Davis. Gastrointestinal transit of non-disintegrating tablets in fed subjects. Int. J. Pharm. 53:107–117 (1989).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Lin, S.Y., Ayres, J.W. Calcium Alginate Beads as Core Carriers of 5-Aminosalicylic Acid. Pharm Res 9, 1128–1131 (1992). https://doi.org/10.1023/A:1015887318767
Issue Date:
DOI: https://doi.org/10.1023/A:1015887318767